Known hypersensitivity to Zoledronic Acid, any other bisphosphonate or any components of Zoruxa; hypocalcemia; renal failure; zoledronic acid is contraindicated in patients with creatinine clearance <35 mL/min and in those with evidence of acute renal impairment.